Zimbabwe has turned down a significant American healthcare agreement worth 367 million US dollars (£272m) spanning five years because of the United States' request for sensitive information.
This move came to light after a government memo from December was disclosed, indicating that President Emmerson Mnangagwa felt the arrangement was "unbalanced".
A government spokesperson later stated that the US was seeking genetic material for research and profit while was not willing to guarantee the resulting advantages from any future vaccines.
"We must now begin the challenging and unfortunate process of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had furnished over $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has urged further negotiations to secure a deal suitable to all parties so the country's vital HIV treatment initiative can proceed.
Broader Context
This development follows a similar case in Kenya, where a court suspended a related health funding agreement after legal challenges were raised about the security of citizens' health data.
Since resuming office last year, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
USAID had overseen assistance for the US government, but Trump argued its expenditure was "wasteful" and his administration was pursuing government-to-government deals to enhance transparency and responsibility.
Based on statements, 16 African countries have so far agreed to these new agreements, constituting more than $18.3bn in committed funds.
Details of the Rejected Deal
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this partnership might have yielded significant benefits for Zimbabwean communities, particularly the 1.2 million currently on HIV treatment through US-supported programmes," Tremont commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"The proposal required Zimbabwe to provide its biological resources and data indefinitely, without any equivalent guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," Mangwana explained.
"Put simply, our country would supply the raw materials for scientific discovery with no certainty that the final treatments would be accessible to our population if a new health crisis arise."
National Interest and International Frameworks
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were upending structures already established through the international health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing system designed to manage future pandemics.
"This system is intended to ensure that when a nation contributes its data, the resulting advantages – including medicines and cures – are shared equitably, not monopolised solely by those with the funds to develop them."
These objections regarding the US deal "should not be misconstrued as opposition to America," he added.
"We are open to further dialogue with our American counterparts on how future co-operation might be arranged in a manner that respects the independence and interests of both nations."
Medical Community Response
Medical experts said it recognised the government's concerns, but suggested that talks need to persist given that a large portion of the nation's Aids initiatives were funded by external financing.
"If specific concerns exist, including those involving data governance or agreement terms, these can frequently be addressed through detailed discussion and negotiated safeguards," the group said.
The situation underscores the continuing challenges between accepting crucial foreign assistance and protecting national sovereignty in an ever more interconnected world.